China HeadAche DIsorders RegiStry

Launched by BEIJING TIANTAN HOSPITAL · Apr 13, 2022

Keywords

ClinConnect Summary

The China HeadAche DIsorders Registry (CHAIRS) is a clinical trial that aims to better understand different types of headaches, including migraines and tension-type headaches, as well as headaches caused by medication overuse. The study plans to enroll 10,000 patients aged 12 years and older. Researchers will collect various information from participants, such as their medical history, genetic factors, and how headaches affect their daily lives. The goal is to learn more about these conditions and find better ways to treat them over the long term.

To be eligible for this study, participants must be at least 12 years old and have experienced their first headache before the age of 50. The headaches should be classified as primary headaches, which means they are not caused by any other medical condition, or they can be headaches complicated by medication overuse. Participants will need to sign a consent form and will be followed for their symptoms and responses to treatments over time. It's important to note that individuals with severe mental health issues, serious illnesses, pregnant or breastfeeding women, and those currently involved in other clinical trials will not be able to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥ 12 years old,Any gender;
• • 2. The first onset age of primary headache was less than 50 years old(Age \<65 years at first diagnosis of chronic migraine);
• • 3. patients with primary headache (migraine, tension headache and other types of primary headache) or primary headache complicated with MOH according to ICHD-3;
• • 4. Sign the informed consent form.
• Exclusion Criteria:
• • 1. According to the ICHD-3 diagnostic criteria, there are still headaches directly related to secondary factors (except drug overuse) at the time of enrollment;
• • 2. Those who cannot be diagnosed as primary headache or primary headache combined with medication overuse headache according to ICHD-3;
• • 3. According to DSM-V diagnostic criteria, patients with severe mental diseases (such as schizophrenia, mental disorders associated with mental retardation, etc.);
• • 4. Patients with severe organic diseases, such as malignant tumors, and the expected survival time is less than 1 year;
• • 5. Pregnant,planning pregnancy or Lactating women;
• • 6. Subjects participating in other clinical trials;
• • 7. Unable to cooperate to complete the follow-up due to geographical or other reasons